Checked · GMP unchanged since
Detailed financials for this issue aren’t available yet.
| Application | Shares | Amount at ₹106 |
|---|---|---|
| Individual investor (min)minimum application | 2,400 | ₹2,54,400 |
The minimum application is 2,400 shares, ₹2,54,400 at the ₹106 cut-off. Since 1 July 2025 SME issues take a minimum application of ₹2,00,000 or more from individual investors; the HNI minimum is set in the RHP. Amounts are shown at the upper band because applications are made at the cut-off price.
Himalaya Nutravedics India Limited manufactures and markets Ayurvedic and Nutraceutical formulations in India. It also undertakes third-party contract manufacturing. The company's product portfolio includes classical Ayurvedic formulations, proprietary Ayurvedic formulations, and nutraceutical supplements across multiple dosage forms. Its products are used in areas such as digestive health, immunity, metabolic health, and general wellness. The company was incorporated in 2022.
Strengths and risk factors from this issue’s prospectus aren’t available yet.
Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Himalaya Nutravedics, the registrar is Kfin Technologies Limited — allotment is finalised in the days between the issue closing on 24 Sept 2026 and listing on 29 Sept 2026.
Allotment and refund dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them. alphave does not hold allotment results — only the registrar can show whether an application was allotted.
The registrar publishes allotment on its own portal: KFintech. Your bank will also show the blocked amount released if shares were not allotted.
The Himalaya Nutravedics IPO price band is ₹100 to ₹106 per share. Applications are made at the cut-off price, which is the upper end of the band.
One lot is 2400 shares, so a single application at the ₹106 cut-off costs ₹2,54,400. One lot already exceeds the ₹2,00,000 retail limit, so this issue can only be applied for in the HNI category.
₹2,54,400 — one lot of 2400 shares at ₹106. Bids in the non-institutional category start above ₹2,00,000 and are made in multiples of the lot.
Himalaya Nutravedics is an SME issue listing on NSE SME. SME issues have a larger minimum lot and trade on the exchange's SME platform after listing. The lead manager is Nirbhay Capital Services Private Limited.
The issue size is ₹26.5 crore, of which ₹26.5 crore is a fresh issue.
The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.
Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹0 on a ₹106 upper band means the grey market is dealing at ₹106.
The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.
Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.